Oxford/AstraZeneca COVID shot less effective against South African variant: study

dxx

Well-known member
  • Dec 26, 2011
    11,804
    10,522
    113
    (Reuters) - British drugmaker AstraZeneca AZN.L said on Saturday its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of COVID-19, based on early data from a trial.

    Xv8Dh0v.jpg


    The study from South Africa’s University of the Witwatersrand and Oxford University showed the vaccine had significantly reduced efficacy against the South African variant, according to a Financial Times report published earlier in the day.

    Among coronavirus variants currently most concerning for scientists and public health experts are the so-called British, South African and Brazilian variants, which appear to spread more swiftly than others.

    “In this small phase I/II trial, early data has shown limited efficacy against mild disease primarily due to the B.1.351 South African variant,” an AstraZeneca spokesman said in response to the FT report.

    https://www.reuters.com/article/uk-...ent&utm_medium=trueAnthem&utm_source=facebook
     

    imhotep

    Well-known member
  • Mar 29, 2017
    6,566
    6
    4,956
    113
    Both AZ and BioNTech are working on how to reconfigure the vaccine to deal with the South African variant.